Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects

Annals of Nutrition and Metabolism

Volumn 52, Issue 4, 2008, Pages 329-334

  Al Mutairi, Sana S ^a   Mojiminiyi, Olusegun A ^a   Shihab Eldeen, Aida A ^a   Al Sharafi, Ahmad ^a   Abdella, Nabila ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Adiponectin; Leptin; Receptors, leptin; Smoking

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; LEPTIN; LEPTIN RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DOSE RESPONSE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOKING HABIT;

ADIPOKINES; ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; MIDDLE AGED; RECEPTORS, LEPTIN; SMOKING;

NICOTIANA TABACUM;

EID: 49549111135     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151487     Document Type: Article

References (32)

1. Hodge AM, Westerman RA, de Courten MP, Collier GR, Zimmet PZ, Alberti KG: Is leptin sensitivity the link between smoking cessation and weight gain? Int J Obes Relat Metab Disord 1997;21:50-53.
2. Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, Ouchi K, Ohashi K, Kihara S, Funahashi T, Rakugi H, Ogihara T: Association of hypoadiponectinemia with smoking habit in men. Hypertension 2005;45:1094-1100.
3. James PT, Rigby N, Leach R; International Obesity Task Force: The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004;11:3-8.
4. Rexford S, Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327-332.
5. Matsuzawa Y: The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-2921.
6. Van Gaal LF, Mertens IL, De Block CE: Mechanisms linking obesity with cardiovascular disease insight. Nature 2006;444:875-880.
7. Meier U, Gressner AM: Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50:1511-1525.
8. Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J: Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 2001;283:982-988.
9. Huang L, Wang Z, Li C: Modulation of circulating leptin levels by its soluble receptor. J Biol Chem 2001;276:6343-6349.
10. Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327-332.
11. Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A: Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with type 2 diabetes. Int J Obes 2007;31:213-220.
12. Mantzoros CS, Liolios AD, Tritos NA, Kaklamani VG, Doulgerakis DE, Griveas I, Moses AC, Flier JS: Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men. Obes Res 1998;6:179-186.
13. Jaleel A, Jaleel F, Majeed R, Alam E: Leptin and blood lipid levels in smokers and exsmokers. World Appl Sci 2007;2:348-352.
14. Fernandez-Real JM, Broch M, Vendrell J, Ricart W: Smoking, fat mass and activation of the tumor necrosis factor-α pathway. Int J Obes 2003;27:1552-1556.
15. Larsson H, Ahren B: Smoking habits and circulating leptin in postmenopausal non-obese women. Diabetes Obes Metab 1999;1:57-59.
16. Togo M, Hashimoto Y, Futamura A, Tsukamoto K, Satoh H, Hara M, Watanabe T, Nakarai H, Nakahara K, Kimura S: Relationship between the serum level of leptin and life-style habits in Japanese men. Horm Res 2000;54:169-173.
17. Eliasson B, Smith U: Leptin levels in smokers and long-term users of nicotine gum. Eur J Clin Invest 1999;29:145-152.
18. Al Mutairi SS, Shihab-Eldeen AA, Mojiminiyi OA, Anwar AA: Comparative analysis of the effects of hubble-bubble (Sheesha) and cigarette smoking on respiratory and metabolic parameters in hubble-bubble and cigarette smokers. Respirology 2006;11:449-455.
19. Friedewald WT, Levy RT, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972;18:449-502.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-419.
21. Grassi G, Seravelle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, Mancia G: Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994;90:248-253.
22. Gettys TW, Harkness PJ, Watson PM: The β3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 1996;137:4054-4057.
23. Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, Laquier F, Manetta J, Bue-Valleskey J, Stephens TW: Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996;271:5301-5304.
24. Chen H, Hansen MJ, Jones JE, Vlahos R, Bozinovski S, Anderson GP, Morris MJ: Cigarette smoke exposure reprograms the hypothalamic neuropeptide Y axis to promote weight loss. Am J Respir Crit Care Med 2006;173:1248-1254.
25. Margetic S, Gazzola C, Pegg GG, Hill RA: Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002;26:1407-1433.
26. Wei M, Stern MP, Haffner SM: Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol 1997;7:81-86.
27. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM: Insulin resistance and cigarette smoking. Lancet 1992;339:1128-1130.
28. Attvall S, Fowelin J, Lager I, Von-Schenck H, Smith U: Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J Intern Med 1993;233:327-232.
29. Eliasson B, Attvall S, Taskinen MR, Smith U: The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 1994;14:1946-1950.
30. Safeer RS, Cornell MO: The emerging role of HDL cholesterol. Is it time to focus more energy on raising high-density lipoprotein levels? Postgrad Med 2000;108:87-90.
31. Chaldakov GN, Stankulov IS, Hristova M, Ghenev PI: Adipobiology of disease: adipokines and adipokines-targeted pharmacology. Curr Pharm Des 2003;9:1023-1031.
32. Boden G, Cheung P, Mozzoli M, Fried SK: Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism 2003;52:753-759.